You are here
Coronavirus (COVID-19): Information on medicines and medical devices
The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.
Please read the information below before contacting the TGA to see if your question is already answered.
Filters
Topics and product types
I want to
- Find out about medicine shortages and restrictions (5) Apply Find out about medicine shortages and restrictions filter
- Report a perceived breach or questionable practices (1) Apply Report a perceived breach or questionable practices filter
- Supply a COVID-19 test kit (3) Apply Supply a COVID-19 test kit filter
- Supply a face mask, gloves or gown (1) Apply Supply a face mask, gloves or gown filter
27 October 2021
A list of disinfectant products included in the ARTG with specific claims against SARS-Cov-2 (COVID 19) or COVID-19 on the product label.
27 October 2021
The TGA is undertaking a post-market review of face masks included in the ARTG. This page lists all face masks that have been cancelled from the ARTG during the review.
27 October 2021
COVID-19 vaccine batch release information is now available.
27 October 2021
The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.
27 October 2021
The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.
27 October 2021
The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.
27 October 2021
COVID-19 vaccines undergoing evaluation for provisional registration by the TGA
22 October 2021
This document provides the TGA's assessment on the protection offered by certain COVID-19 vaccines that are administered in certain countries but not currently registered in Australia.
22 October 2021
The TGA is undertaking a post-market review of all face masks included in the Australian Register of Therapeutic Goods to ensure the quality and effectiveness of face masks.
21 October 2021
On 15 October 2021 the TGA granted provisional approval to Roche Products Pty Ltd for its COVID-19 treatment - casirivimab + imdevimab (RONAPREVE) - making it the third COVID-19 treatment to receive regulatory approval in Australia.
Pages
Further information
Contact TGA Info
Tel: 1800 020 653
Email: info@tga.gov.au
Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.
Department of Health
Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.
Follow us
